Patents Assigned to MILLIPEDE, INC.
  • Patent number: 10335275
    Abstract: Methods related to delivery of various heart valve implants are described. The implant may be delivered using an ultrasound imaging delivery system. The ultrasound imaging delivery system may be used to deliver a variety of different devices, including mitral valve reshaping devices, mitral valve replacement valves, and others. A deployment catheter carrying an implant having a tissue anchor is advanced to a deployment site in a heart. An imaging element is positioned adjacent the implant and a relationship between the tissue anchor and an anatomical landmark in the heart is visualized. The implant is then attached by driving the tissue anchor into tissue in the heart.
    Type: Grant
    Filed: September 29, 2016
    Date of Patent: July 2, 2019
    Assignee: MILLIPEDE, INC.
    Inventors: Randall Lashinski, Kristian Kristoffersen, Matthew Rust, Richard Glenn, Michael Lee, Patrick Macaulay
  • Patent number: 9192471
    Abstract: In general, in an aspect, an annulus of a heart valve is caused to dilate to a predetermined configuration by pushing a delivery tool distally through the annulus from one heart chamber to another heart chamber. A valve support is attached to the delivery tool. The valve support has a plurality of barbs or hooks attached thereon. While the annulus is dilated, the valve support is attached to tissue at locations along the annulus by attaching the barbs or hooks to the tissue. After attachment, the support is caused to contract.
    Type: Grant
    Filed: January 8, 2007
    Date of Patent: November 24, 2015
    Assignee: MILLIPEDE, INC.
    Inventor: Steven F. Bolling
  • Patent number: 9180005
    Abstract: Excessive dilation of the annulus of a mitral valve may lead to regurgitation of blood during ventricular contraction. This regurgitation may lead to a reduction in cardiac output. Disclosed are systems and methods relating to an implant configured for reshaping a mitral valve. The implant comprises a plurality of struts with anchors for tissue engagement. The implant is compressible to a first, reduced diameter for transluminal navigation and delivery to the left atrium of a heart. The implant may then expand to a second, enlarged diameter to embed its anchors to the tissue surrounding and/or including the mitral valve. The implant may then contract to a third, intermediate diameter, pulling the tissue radially inwardly, thereby reducing the mitral valve and lessening any of the associated symptoms including mitral regurgitation.
    Type: Grant
    Filed: December 5, 2014
    Date of Patent: November 10, 2015
    Assignee: MILLIPEDE, INC.
    Inventors: Randall Lashinski, Matthew Rust, Patrick Macaulay, Terry Wayne Daniels, Kris Kristoffersen